UBS Maintains Buy on Aemetis, Lowers Price Target to $7.75
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Manav Gupta maintains a Buy rating on Aemetis (NASDAQ:AMTX) but lowers the price target from $8.25 to $7.75.
August 19, 2024 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
UBS analyst Manav Gupta maintains a Buy rating on Aemetis but lowers the price target from $8.25 to $7.75.
The Buy rating suggests continued confidence in Aemetis, but the lowered price target indicates a slightly less optimistic outlook. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100